You are here

Health

Mercy Health – St. Rita’s Imaging Services expands

Mercy Health has expanded access for outpatient ultrasound imaging to Mercy Health – Wapakoneta Imaging Services, 1015 South Blackhoof St., Suite D.. Other locations include Mercy Health – Putnam County MedicalCenter and Mercy Health – St. Rita’s Medical Center.

“Imaging services offer opportunity for early detection and diagnosis, which saves lives,” said Patricia Giesken, Director of Imaging Services at Mercy Health – St. Rita’s Medical Center. 

“At Mercy Health, we try to give the community as many access points for treatment and comprehensive care. Especially because the health and well-being of the community is one of our top priorities.”

Manage your diabetes with the ABCs

Note: this article is provided by ONU Healthwise Pharmacy.
If you have been diagnosed with diabetes, you may feel overwhelmed — and that’s understandable. But you can take steps to both ease your anxiety and get on the road to effective diabetes management.

Understand Your Condition

Type 2 diabetes is a condition in which there is too much glucose (sugar) in your blood because your body does not make or use insulin well.

Over time, having too much glucose in your blood can cause serious health problems. Diabetes can damage your eyes, kidneys, and nerves and increase your risk of heart disease and stroke.

FDA approves new injection to treat hives

Note: this article is provided by ONU Healthwise Pharmacy.
There's a newly approved treatment for hives.

The US Food and Drug Administration (FDA) has approved Quzyttir (cetirizine) to treat acute urticaria (hives).

Available as an injection to be given into the vein (IV), this new medication is approved for adults and children 6 months of age and older.

Cetirizine injection is now an alternative treatment option to IV diphenhydramine (brand name Benadryl).

The approved dose is once every 24 hours as needed for acute hives.

New migraine med approved

FDA approves Reyvow (lasmiditan)

Note: this article is provided by ONU Healthwise Pharmacy.
A new migraine medication is hitting the market.

The US Food and Drug Administration (FDA) has approved Reyvow (lasmiditan) to treat migraines.

Migraines are estimated to affect more than 10 percent of people around the world.

Lasmiditan, available in tablet form, has been approved for adults with migraines with or without aura.

Aura is a sensory phenomenon or visual disturbance. An aura can occur as flashing lights, zig-zag lines or temporary vision loss. Auras typically affect around one-third of people who have migraines.

Four mammogram myths debunked

Note: this article is provided by ONU Healthwise Pharmacy.
For Breast Cancer Awareness Month, we're debunking four common mammogram myths.

Mammograms are low-dose X-ray pictures of the breast. Because mammography can detect breast cancer tumors before they can be felt, screening is very important for early detection. And early breast cancer detection has been linked to higher chances of survival. Speak with your doctor about how often you should be screened for breast cancer. For more information on performing a breast self-exam and detecting breast changes, check out Detecting Breast Cancer Early.

E-Cigs remain under investigation

FDA continues to warn consumers of potential risks of vaping

Note: this article is provided by ONU Healthwise Pharmacy.
Health officials continue to investigate e-cigarettes as the number of reported respiratory problems tied to vaping continues to rise.

Recently, the US Food and Drug Administration (FDA) issued a warning about a possible risk of respiratory issues tied to e-cig products. At the end of August, the FDA stated that 25 states had reported 215 possible cases of such issues.

The FDA said it is working closely with the Centers for Disease Control and Prevention (CDC) and other government partners to investigate recent severe lung injuries and deaths tied to vaping.

Pages